Treatment Resistant Depression

This book presents current research on depression and antidepressants, including use of antidepressants in alcohol use disorders and pregnancy, treatment-resistant depression, and development of potential new medications.

“A thorough, up-to-date, and upbeat introduction to current scientific thinking about mood disorders and their treatment. An important resource for patients and their families—and for anyone curious about progress in psychiatric research."―Peter D. Kramer, Listening to Prozac

This volume uses multidisciplinary approaches to physiological and cognitive mechanisms, medical treatment, psychosocial interventions, and self-management to help illustrate the complex association among the COVID-19 pandemic, neurological manifestations, mental health, and society.

New York Times best-selling author Dr. Mike Dow and Ronan Levy, founder of Field Trip, the world's largest provider of psychedelic-assisted psychotherapies, offer ways to integrate ketamine into treatment for depression, anxiety, PTSD, and more.

Given the unacceptably high rates of suffering, disability and premature death experienced by people with treatment-resistant depression and the surprisingly low rates of problems arising from the use of ketamine to treat the disorder, this is a therapy that all patients and their doctors should be discussing.